Native human GLP-1 has a bloodstream half-life of only about 2 minutes due to rapid degradation by the DPP-4 enzyme, making it useless as a standalone drug.
Snapshot · The Peter Attia Drive
Native human GLP-1 has a bloodstream half-life of only about 2 minutes due to rapid degradation by the DPP-4 enzyme, making it useless as a standalone drug.
Where this was said
At 49:50 · chapter starts 47:30
In the late 1980s, clinical endocrinologist John Eng was seeing veterans with diabetes at the Bronx VA Medical Center and moonlighting in Rosalind Yalow's lab, which had developed uniquely sensitive peptide hormone assays using radioimmunoassay technology. Eng had read that Gila monster bites caused dramatic pancreatic inflammation in bitten animals, and he was struck by an additional fact: the Gila monster eats only 3 or 4 meals a year yet maintains stable blood glucose throughout long fasts — suggesting its pancreatic biology was doing something unusual. He ordered dried Gila monster venom and ran it through Yalow's assays. [1] — Peter Attia "Exendin-4 has 53% similarity to human GLP-1: Exendin-4, a peptide in Gila monster venom discovered by John Eng, showed 53% amino acid seque…" 48:58 Working with colleague Jean-Pierre Rothman, he systematically separated the peptide components, identified two peptides, and named the new one Exendin-4. When he sequenced it, the result was remarkable: 53% amino acid similarity to human GLP-1, the gut hormone that stimulates insulin secretion after meals. More importantly, while native GLP-1 has a half-life of only about 2 minutes — degraded almost instantly by the enzyme DPP-4 — Exendin-4 is resistant to DPP-4 and has a half-life measured in hours. Eng had discovered a long-acting GLP-1 receptor agonist hiding in lizard saliva. [2] — Peter Attia "Native GLP-1 half-life: ~2 minutes: Native human GLP-1 has a bloodstream half-life of only about 2 minutes due to rapid degradation by the …" 49:50 The VA declined to patent the discovery; Eng patented it himself and licensed it, eventually to Eli Lilly and Amylin. In 2005, the FDA approved synthetic Exendin-4 as Byetta (exenatide), the first GLP-1 receptor agonist. Subsequent drugs — liraglutide, semaglutide, tirzepatide — built on the biology, reducing immunogenicity and extending duration. The class is now reshaping the treatment of type 2 diabetes, obesity, and cardiovascular disease, with ongoing trials in heart failure, kidney disease, sleep apnea, addiction, and Alzheimer's disease.
The Gila monster eats only 3 or 4 meals per year yet maintains remarkably stable blood glucose levels throughout prolonged fasting, which drew John Eng's scientific attention.
Exendin-4, a peptide in Gila monster venom discovered by John Eng, showed 53% amino acid sequence similarity to human GLP-1, explaining its potent pancreatic effects.
The U.S. Surgeon General's 2023 report on loneliness found that half of American adults report feeling lonely, marking a widespread epidemic of social isolation.
In a peer-reviewed study, Brain.fm's audio technology was shown to increase focus-related brainwave activity by 119%, according to the show's sponsor read.
The Easterlin Paradox shows that wealthier nations — and the wealthiest neighborhoods within them — tend to have the highest rates of anxiety, depression, loneliness, and suicide.
Mental health challenges are nearly universal — BetterHelp's own research found the majority of Americans experiencing symptoms right now.
When applying for Medicaid to cover nursing home costs, there is a 5-year look-back period that can disqualify applicants who gave away or spent down assets.
A broken pipe filled the Bad Friends studio with what the hosts identified as hydrogen sulfide — microscopic fecal aeroparticles — that the crew denied smelling.
Fei-Fei Li's father's liver surgery performed by a da Vinci robot resulted in 10 times less blood loss than a typical open liver surgery, thanks to laparoscopic precision.
Approximately 115 million adults in the US currently have prediabetes, most of whom are unaware, according to the Lingo sponsor segment.
Drug overdose deaths in the US fell from 110,000 to 80,000 in 2024, and then to roughly 70,000 — the largest single-year drop the CDC has ever recorded.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.